NewBridge Pharmaceuticals ^Company

NewBridge Pharmaceuticals is a pharmaceutical and medical device company that focuses on developing innovative therapies for the Middle East and North Africa (MENA) region. Founded in 2010, their mission is to bridge the access gap in MENA countries and provide life-saving treatments to patients and their families. They offer a range of oncology and supportive care products, including treatments for bone metastasis and chemotherapy-induced nausea and vomiting. With headquarters in Dubai, United Arab Emirates, NewBridge Pharmaceuticals serves biotechnology and pharmaceutical companies in the MENA region, including Saudi Arabia, Lebanon, Egypt, and Libya.